Ethinyl estradiol / norelgestromin Pregnancy and Breastfeeding Warnings

Ethinyl estradiol / norelgestromin is also known as: Ortho Evra, Xulane

Ethinyl estradiol / norelgestromin Pregnancy Warnings

Ethinyl estradiol-norelgestromin transdermal patch has been assigned to pregnancy category X by the FDA. There is no indication for the use of hormonal contraceptive combinations during pregnancy. Although some reports have suggested that oral contraceptive hormones may cause a variety of congenital malformations, recent studies (including a meta-analysis of prospective studies) have suggested that an association between oral contraceptive use and congenital malformations does not exist. Some progestins may cause masculinization of female infants.

Ethinyl estradiol / norelgestromin Breastfeeding Warnings

There are no data on the excretion of ethinyl estradiol and norelgestromin (transdermal patch) into human milk. Contraceptive steroids given in the postpartum period may interfere with the quality and quantity of breast milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web1)